Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.

Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.
复制标题

DOI:
10.1038/gt.2012.76
复制
发表时间:
2013-06
期刊:
影响因子:
5.1
通讯作者:
Spencer, H. T.
Spencer, H. T.
中科院分区:
医学3区
文献类型:
--
作者:
Johnston, J. M.;Denning, G.;Doering, C. B.;Spencer, H. T.

文献摘要

参考文献

被引文献

相似文献

We previously compared the expression of several human factor VIII (fVIII) transgene variants and demonstrated the superior expression properties of B domain deleted porcine fVIII. Subsequently, a hybrid human/porcine fVIII molecule (HP-fVIII) comprising 91% human amino acid sequence was engineered to maintain the high-expression characteristics of porcine fVIII. The bioengineered construct then was used effectively to treat knockout mice with hemophilia A. In the current study, we focused on optimizing self-inactivating (SIN) lentiviral vector systems by analyzing the efficacy of various lentiviral components in terms of virus production, transduction efficiency and transgene expression. Specifically, three parameters were evaluated: 1) the woodchuck hepatitis post-transcriptional regulatory element (WPRE), 2) HIV versus SIV viral vector systems, and 3) various internal promoters. The inclusion of a WPRE sequence had negligible effects on viral production and HP-fVIII expression. HIV and SIV vectors were compared and found to be similar with respect to transduction efficiency in both K562s and HEK-293T cells. However, there was an enhanced expression of HP-fVIII by the SIV system, which was evident in both K562 and BHK-M cell lines. To further compare expression of HP-fVIII from an SIV-based lentiviral system, we constructed expression vectors containing the high expression transgene and a human elongation factor-1 alpha (EF1α), cytomegalovirus (CMV) or phosphoglycerate kinase (PGK) promoter. Expression was significantly greater from the CMV promoter, which also yielded therapeutic levels of HP-fVIII in hemophilia A mice. Based on these studies, an optimized vector contains the HP-fVIII transgene driven by a CMV internal promoter within a SIV-based lentiviral backbone lacking a WPRE.
DOI: 10.1038/nature09328
发表时间: 2010-09-16
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1182/blood-2010-09-306761
发表时间: 2011-05-19
期刊: BLOOD
影响因子: 20.3
作者:
Biffi, Alessandra;Bartholomae, Cynthia C.;Montini, Eugenio
通讯作者: Montini, Eugenio
DOI: 10.1038/mt.2009.35
发表时间: 2009-07-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Doering, Christopher B.;Denning, Gabriela;Spencer, H. Trent
通讯作者: Spencer, H. Trent
DOI: 10.1126/science.1171242
发表时间: 2009-11-06
期刊: SCIENCE
影响因子: 56.9
作者:
Cartier, Nathalie;Hacein-Bey-Abina, Salima;Aubourg, Patrick
通讯作者: Aubourg, Patrick
DOI: 10.1074/jbc.m312451200
发表时间: 2004-02-20
影响因子: 4.8
作者:
Doering, CB;Healey, JF;Lollar, P
通讯作者: Lollar, P